Market OverviewThe Orphan Drugs Market is a specialized sector within the pharmaceutical industry that focuses on the ...
Recently, a letter to the editor I wrote was published in the Arkansas Democrat-Gazette on the subject of skyrocketing health-care costs, inclusive of rising pharmaceutical drug prices. I referenced ...
The process of separating useful molecules from mixtures of other substances accounts for 15% of the nation's energy, emits ...
A lawsuit filed Monday contends that Yale New Haven Health System bears some of the blame for drug diversions by a nurse that ...
A new report from industry trade group the Pharmaceutical Research and Manufacturers of America (PhRMA) has shed a new light ...
Stay updated with the Cipla Stock Liveblog, your one-stop destination for real-time information and analysis of a leading ...
As detailed in our previous updates, the IRA’s Medicare Drug Price Negotiation Program (the Negotiation Program or Program), ...
Vaccines dominate the poultry pharmaceuticals market due to rising concerns over infectious diseases like Newcastle Disease ...
MRNA's competitive landscape, particularly against Pfizer, and higher forward P/S ratio suggest the stock is overvalued and ...
Vistagen Therapeutics, Inc.'s fasedienol shows promise in treating social anxiety; new results expected 2025. Click for my ...
Corbus Pharmaceuticals presented Phase 1 data on CRB-701 at ASCO GU, showing safety, tolerability, and responses across multiple tumor types.
The supplement industry is booming—but so are serious health issues tied to taking these pills and powders. Here’s what ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results